BRD4 jump-starts transcription after mitotic silencing

Genome Biology

Volumn 12, Issue 11, 2011, Pages

  Voigt, Philipp ^a   Reinberg, Danny ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ANTINEOPLASTIC AGENT; BROMODOMAIN PROTEIN 4; GSK 525762A; JQ 1; PROTEIN INHIBITOR; RNA POLYMERASE II; UNCLASSIFIED DRUG; BRD4 PROTEIN, HUMAN; HISTONE; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

BINDING AFFINITY; CARCINOMA; CHROMATIN; DRUG BINDING; DRUG MECHANISM; GENE LOCUS; MITOSIS INHIBITION; MOLECULAR IMAGING; NONHUMAN; NOTE; PROTEIN BINDING; PROTEIN FUNCTION; TRANSCRIPTION INITIATION; ACETYLATION; ARTICLE; CELL LINE; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; HUMAN CHROMOSOME; METABOLISM; MITOSIS;

ACETYLATION; CELL LINE; CHROMATIN; CHROMOSOMES, HUMAN; GENE EXPRESSION REGULATION; GENES, CDC; HISTONES; HUMANS; MITOSIS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 82255175234     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2011-12-11-133     Document Type: Note

References (10)

1. Zaidi SK, Young DW, Montecino MA, Lian JB, van Wijnen AJ, Stein JL, Stein GS. Mitotic bookmarking of genes: a novel dimension to epigenetic control. Nat Rev Genet 2010, 11:583-589. 10.1038/nrg2827, 3033599, 20628351.
2. Zhao R, Nakamura T, Fu Y, Lazar Z, Spector DL. Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation. Nat Cell Biol 2011, 13:1295-1304. 10.1038/ncb2341, 21983563.
3. Janicki SM, Tsukamoto T, Salghetti SE, Tansey WP, Sachidanandam R, Prasanth KV, Ried T, Shav-Tal Y, Bertrand E, Singer RH, Spector DL. From silencing to gene expression: real-time analysis in single cells. Cell 2004, 116:683-698. 10.1016/S0092-8674(04)00171-0, 15006351.
4. Wu S-Y, Chiang C-M. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J Biol Chem 2007, 282:13141-13145. 10.1074/jbc.R700001200, 17329240.
5. Dey A, Nishiyama A, Karpova T, McNally J, Ozato K. Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription. Mol Biol Cell 2009, 20:4899-4909. 10.1091/mbc.E09-05-0380, 2785733, 19812244.
6. Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, Chung C-W, Chandwani R, Marazzi I, Wilson P, Coste H, White J, Kirilovsky J, Rice CM, Lora JM, Prinjha RK, Lee K, Tarakhovsky A. Suppression of inflammation by a synthetic histone mimic. Nature 2010, 468:1119-1123. 10.1038/nature09589, 21068722.
7. Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, Philpott M, Munro S, McKeown MR, Wang Y, Christie AL, West N, Cameron MJ, Schwartz B, Heightman TD, La Thangue N, French CA, Wiest O, Kung AL, Knapp S, Bradner JE. Selective inhibition of BET bromodomains. Nature 2010, 468:1067-1073. 10.1038/nature09504, 3010259, 20871596.
8. Mertz JA, Conery AR, Bryant BM, Sandy P, Balasubramanian S, Mele DA, Bergeron L, Sims RJ. Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc Natl Acad Sci USA 2011, 108:16669-16674. 10.1073/pnas.1108190108, 3189078, 21949397.
9. Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, Chesi M, Schinzel AC, McKeown MR, Heffernan TP, Vakoc CR, Bergsagel PL, Ghobrial IM, Richardson PG, Young RA, Hahn WC, Anderson KC, Kung AL, Bradner JE, Mitsiades CS. BET Bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 2011, 146:904-917. 10.1016/j.cell.2011.08.017, 21889194.
10. Dawson MA, Prinjha RK, Dittman A, Giotopoulos G, Bantscheff M, Chan W-I, Robson SC, Chung C-W, Hopf C, Savitski MM, Huthmacher C, Gudgin E, Lugo D, Beinke S, Chapman TD, Roberts EJ, Soden PE, Auger KR, Mirguet O, Doehner K, Delwel R, Burnett AK, Jeffrey P, Drewes G, Lee K, Huntly BJ, Kouzarides T. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 2011, 478:529-533. 10.1038/nature10509, 21964340.